HBOT has been shown in some studies to: Improve Blood Chemistry, Advance Glycemic Control, Decrease Cardiovascular Risk, Stimulate Creation of New Blood Vessels, Reduce Inflammation, Improve Brain Function, Reduce Risk of Stroke, Enhance Internal/External Healing, Reduce Amputation Rate.
Diabetes affects more than 12 million people and is the seventh leading cause of death in the U.S. With diabetes primarily affecting the small blood vessels, hyperbaric oxygen therapy (HBOT) has been demonstrated to stimulate angiogenesis to help ameliorate compromised blood flow and prevent organ failure. Research has shown that HBOT can lower blood sugar levels by increasing cellular sensitivity to insulin and skeletal muscle reception of glucose. Furthermore, recent reports have provided evidence towards linking HBOT to regenerating pancreatic islets of Langerhans, thus potentially producing more insulin.
HBOT is often beneficial in treating osteomyelitis and cellulitis, in addition to preventing systemic toxicity and permanent disability. With chronic diabetes, impaired circulation reduces wound healing capability and promotes ulcerations. HBOT increases the amount of oxygen available to ulcerated areas, leading to increased fibroblast activation. Studies have demonstrated the benefits of HBOT for diabetes with the following:
The information presented on this website is not intended as a basis for diagnosis or treatment and does not constitute a medical recommendation for individual health conditions. Content should also not be considered a substitute for care under a licensed medical professional. OBISPO HYPERBARIC supports the FDA for your full informed consent.
MAKE AN APPOINTMENT NOW